首页> 美国卫生研究院文献>Biochemical Journal >Microbiological degradation of bile acids. Metabolites formed from 3-(3a alpha-hexahydro-7a beta-methyl-15-dioxoindan-4 alpha-yl) propionic acid by Streptomyces rubescens.
【2h】

Microbiological degradation of bile acids. Metabolites formed from 3-(3a alpha-hexahydro-7a beta-methyl-15-dioxoindan-4 alpha-yl) propionic acid by Streptomyces rubescens.

机译:胆汁酸的微生物降解。卢氏链霉菌由3-(3aα-六氢-7aβ-甲基-15-二氧杂茚满-4α-基)丙酸形成的代谢物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The metabolism of 3-(3a alpha-hexahydro-7a beta-methyl-1,5-dioxoindan-4 alpha-yl)propionic acid (III), which is a possible precursor of 2,3,4,6,6a beta, 7,8,9,9a alpha,9b beta-decahydro-6a beta-methyl-1H-cyclopenta[f]quinoline-3,7-dione (II) formed from cholic acid (I) by streptomyces rubescens, was investigated by using the same organism. 2. This organism effected amide bond formation, reduction of the carbonyl groups, trans alpha beta-desaturation and R-oriented beta-hydroxylation of the propionic acid side chain and skeleton cleavage, and the following metabolites were isolated as these forms or their derivatives: compound (II), 1,2,3,4 a beta,-5,6,6a beta,7,8,9a alpha,9b beta-dodecahydro-6a beta -methylcyclopental[f][1]benzopyran-3,7-dione (IVa), (1R)-1,2,3,4a beta,5,6,6a beta,7,8,9.9a alpha,9b beta-dodecahydro-1-hydroxy-6a beta-methylcyclopenta[f][1]benzopyran-3,7-dione (IVb), (E)-3-(3aalpha-hexahydro-5 alpha-hydroxy-7a beta-methyl-l-oxo-indan-4 alpha-yl)prop-2-enoic acid (V), (+)-(5R)-5-methyl-4-oxo-octane-1,8-dioic acid (VI), 3-(4-hydroxy-5-methyl-2-oxo-2H-pyran-6-yl)propionic acid (VII) and 3-(3a alpha-hexahydro-1 beta-hydroxy-7a beta-methyl-5-oxoindan-4 alpha-yl)propionic acid (VIII). The metabolites (IVb), (V), (VI) and (VII) were new compounds, and their structures were established by chemical synthesis. 3. The question of whether these metabolites are true degradative intermediates is discussed, and a degradative pathway of compound (III) to the possible precursor of compound (VII), 7-carboxy-4-methyl-3,5-dioxoheptanoyl-CoA (IX), is tentatively proposed. The further degradation of compound (IX) to small fragments is also considered.
机译:1. 3-(3a alpha-hexahydro-7a beta-methyl-1,5-dioxoindan-4 alpha-yl)丙酸(III)的代谢,它可能是2,3,4,6,6a的前体研究了由红链霉菌(Streptomyces rubescens)由胆酸(I)形成的β,7,8,9,9aα,9bβ-十氢-6aβ-甲基-1H-环戊[f]喹啉-3,7-二酮(II)通过使用相同的生物。 2.该生物体实现了酰胺键的形成,羰基的还原,丙酸侧链的反式α-β-去饱和和R定向的β-羟基化以及骨架的裂解,并分离了以下代谢物,它们是这些形式或它们的衍生物:化合物(II),1,2,3,4 a beta,-5,6,6a beta,7,8,9a alpha,9b beta-十二烷基-6a beta-甲基环戊醛[f] [1]苯并吡喃-3,7 -二酮(IVa),(1R)-1,2,3,4a beta,5,6,6a beta,7,8,9.9a alpha,9b beta-十二烷基-1-羟基-6a beta-甲基环戊[f] [1] benzopyran-3,7-dione(IVb),(E)-3-(3aalpha-hexahydro-5 alpha-hydroxy-7a beta-methyl-1-oxo-indan-4 alpha-yl)prop-2-烯酸(V),(+)-(5R)-5-甲基-4-氧代辛烷-1,8-二酸(VI),3-(4-羟基-5-甲基-2-氧代-2H -吡喃-6-基)丙酸(VII)和3-(3aα-六氢-1β-羟基-7aβ-甲基-5-氧代茚满-4α-基)丙酸(VIII)。代谢物(IVb),(V),(VI)和(VII)是新化合物,其结构通过化学合成确定。 3.讨论了这些代谢物是否为真正的降解中间体的问题,并讨论了化合物(III)到化合物(VII)可能的前体7-羧基-4-甲基-3,5-二氧杂庚酸-CoA的降解途径( IX),暂定。还考虑了化合物(IX)进一步降解为小片段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号